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KEYWORDS	
	 Mixed	 ligand	 complexes	 of	 M(II)	 {M =	 Cu(II),	 Ni(II),	 Co(II)	 and	 Zn(II)}	 with	 1,10‐phenanthroline	 (1,10‐Phen)	 and	 Schiff	 base	 namely	 2‐aminomethylthiophenyl‐4‐
bromosalicylaldehyde	 (ATS)	 have	 been	 synthesized.	 These	 metal	 chelates	 have	 been
characterized	 by	 elemental	 analyses,	 IR,	 1H	 NMR,	 solid	 reflectance,	 magnetic	 moment	 and
molar	 conductance.	 Spectral	 data	 showed	 that	 the	 1,10‐phenanthroline	 act	 as	 neutral
bidentate	 ligand	coordinating	to	the	metal	 ion	through	two	nitrogen	donor	atoms	and	Schiff
base	 (ATS)	 acts	 as	 monobasic	 bidentate	 coordinating	 through	 through	 azomethine‐N	 and
phenolic‐oxygen	 groups.	 The	 geometry	 of	 the	 studied	 M(II)	 complexes	 has	 been	 fully
optimized.	The	metal	chelates	have	been	screened	for	their	antimicrobial	activities	using	the
disc	diffusion	method	against	different	selected	types	of	bacteria	and	fungi.	In	vitro	antitumor
activity	assayed	against	two	human	cell	lines	colon	(HCT116)	and	larynx	(HEP2)	cancer	cells.
Solution	equilibrium	studies	were	also	investigated.	
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1.	Introduction	
	
One	 of	 the	 major	 applications	 of	 the	 transition	 metal	
complexes	 is	 their	 evaluation	 as	 antibacterial	 and	 antitumor	
agents	 aiming	 toward	 the	 discovery	 of	 effective	 and	 safe	
therapeutic	agents	for	the	treatment	of	bacterial	infections	and	
cancers.	 In	 addition,	many	 Schiff	 base	 complexes	with	metals	
have	 a	 diverse	 spectrum	 of	 biological	 and	 pharmaceutical	
activities,	 including	 antitumor	 [1,2],	 antifungal	 [3,4],	
antioxidative	[5,6]	and	antibacterial	activities	[7‐9].	Schiff	bases	
and	 their	 complexes	 have	 been	 used	 as	 biological	 models	 to	
understand	 the	 structure	 of	 biomolecules	 and	 biological	
processes	 [10].	 The	 study	 of	 ternary	 complexes	 involving	 an	
aromatic	Schiff	base	and	1,10‐phenanthroline	has	been	studied	
extensively	 [11].	 It	 is	 well	 known	 that	 some	 drugs	 exhibit	
increased	activity	when	administered	as	metal	complexes	[12‐
14]	 and	 several	 metal	 chelates	 have	 been	 shown	 to	 inhibit	
tumor	growth	[15].	Some	research	groups	found	that	the	Schiff	
base	 metal	 complexes	 derived	 from	 salicylaldehyde	 can	
specially	 cleave	 the	 DNA	 [16,17].	 As	 it	 is	 known	 to	 all,	
thiophene	 derivatives	 have	 intensively	 antibacterial	 and	
antitumor	 activities	 [18‐20].	 Also,	 metal	 complexes	 of	 Schiff	
bases	 with	 heterocyclic	 compounds	 find	 applications	 as	
potential	drugs	 [7,8,21].	1,10‐Phenanthroline	 (Figure	1)	 is	 the	
parent	of	 an	 important	class	of	chelating	agents.	Considerable	
attention	has	been	paid	 in	recent	years	 to	 the	 investigation	of	
the	 complex‐forming	 properties	 of	 1,10‐phenanthroline	
because	 of	 its	 outstanding	 biological	 significance	 [22,23].	
Previously,	 we	 have	 reported	 our	 interesting	 results	 on	 the	
synthesis,	 equilibrium	 studies	 and	 antimicrobial	 activities	 of	
binary	complexes	of	2‐aminomethylthiophenyl‐4‐bromosalicyl‐
aldehyde	(ATS)	(Figure	1)	[20].	Encouraged	by	this	result	and	
in	 continuation	 of	 our	 published	 work	 in	 the	 coordination	
chemistry	of	bioactive	ligands	[24‐30],	we	turned	our	attention	
towards	the	synthesis,	spectral	characterization	and	biological	
studies	 of	 ternary	 complexes	 involving	 some	 transition	metal	
ions,	 1,10‐Phenanthroline	 (1,10‐phen)	 and	 ATS	 specially	 a	
thorough	literature	survey	reveals	that	no	work	has	been	done	
on	the	synthesis	and	biological	studies	of	ternary	complexes	of	
Schiff	base	containing	thiophene	moiety	and	phenanthroline.	
	
 
 
 	
Figure	1.	Structural	formula	of	ATS‐Schiff	base	and	1,10‐phen.
	
2.	Experimental	
	
2.1.	Materials	
	
All	 chemicals	 used	were	 of	 analytical	 reagent	 grade	 (AR),	
and	 of	 the	 highest	 purity	 available.	 They	 included	 CuCl2.2H2O	
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(Sigma),	CoCl2.6H2O	and	NiCl2.6H2O	(BDH),	ZnCl2.2H2O,	C2H5OH	
(Sigma),	DMSO	(BDH),	5‐bromosalicylaldehyde	(Aldrich);	1,10‐
phenanthroline	 (Sigma)	 and	 2‐aminomethylthiophene	
(Aldrich).	
	
	2.2.	Preparation	of	Schiff	base	
	
The	ATS	Schiff	base	was	prepared	as	reported	in	literature	
[20]	 by	mixing	 an	 ethanolic	 solution	 (20	mL)	 of	 2.01	 g	 (0.01	
mol)	 of	 5‐bromosalicylaldehyde	 with	 1.13	 g	 (0.01	 mol)	 of	 2‐
aminomethylthiophene	 in	 the	 same	 volume	 of	 ethanol.	 The	
mixture	then	refluxed	with	stirring	for	1	hour.	The	precipitate	
was	 collected	 by	 filtration	 through	 Buchner	 funnel,	
recrystallized	 from	 ethanol	 and	 dried	 at	 room	 temperature	
with	89	%	yield.	
	
2.3.	Preparation	of	mixed‐ligand	complexes	
	
1,10‐Phenanthroline	 and	 the	 transition	 metal	 chlorides	
were	used	as	purchased	without	 any	 further	purification.	The	
mixed	ligand	complexes	under	investigation	were	prepared	by	
mixing	 the	 appropriate	 molar	 quantity	 of	 ligands	 and	 metal	
chloride	 using	 the	 following	 procedure.	 An	 ethanolic	 solution	
mixture	 of	 Schiff	 base	 (ATS)	 (20	mL;	 0.1mole)	 and	 1,10‐phen	
(20	 mL;	 0.1	 mole)	 was	 refluxed	 with	 the	 aqueous‐ethanolic	
solution	of	metal	 salt	 (20	mL;	0.1	mole)	 for	4‐5h.	The	colored	
solid	 product	 formed	 was	 filtered,	 washed	 with	 ethanol,	 and	
dried	 in	 a	 desiccator	 over	 anhydrous	 calcium	 chloride	 under	
vacuum.	The	yield	ranged	from	71‐77	%.	The	dried	complexes	
were	subjected	to	elemental	and	spectroscopic	analysis.	
	
2.4.	Molecular	modeling	
	
All	quantum	mechanics	computations	have	been	performed	
using	the	Gaussian	09W	program	package	[31].	Optimization	of	
the	 structures	 of	 the	 ligands	 and	 of	 the	metal	 (II)	 complexes	
was	 carried	 out	 at	 the	 DFT/	 B3LYP	 [32‐34]	 level	 of	 theory	
using	 the	 Lanl2dz	 basis	 set	 [35,36].	 All	 geometric	 parameters	
were	 allowed	 to	 relax	 and	 the	 global	minimum	 structure	 has	
been	 identified	 by	 calculating	 the	matrix	 of	 second	derivative	
and	ensures	that	all	its	Eigen	values	are	positive.	Natural	bond	
order	 analysis	 has	 been	 carried	 out	 using	 NBO	 3.0	 program	
[37,38]	as	implemented	in	the	G09W	package.	
	
2.5.	Pharmacology	
	
2.5.1.	In	vitro	antibacterial	and	antifungal	activities	
	
The	synthesized	complexes	were	screened	in	vitro	for	their	
biological	 activity	 by	 using	 four	 bacteria,	 namely	 Shigella	
flexneri,	Proteous	 vulgaris	 as	 Gram	 –ve,	 Staphylococcus	aureus	
and	 Bacillus	 subtillis	 as	 Gram	 +ve	 and	 two	 fungi,	 namely	
Aspergillus	 fumigatus	 and	 Candida	 albicans.	 These	 bacterial	
strains	 were	 chosen	 as	 they	 are	 known	 human	 pathogens.	
Antimicrobial	 activity	 of	 the	 tested	 samples	 was	 determined	
using	 a	modified	Kirby‐Bauer	 disc	 diffusion	method	 [39].	 The	
stock	solution	 (1	mg/mL)	of	 the	 test	 chemical	 compound	was	
prepared	by	dissolving	20	mg	of	the	test	compound	in	20	mL	of	
dimethyl	 sulfoxide	 (DMSO)	solvent.	Briefly,	 100	μL	of	 the	 test	
bacteria/fungi	were	grown	in	10	mL	of	 fresh	media	until	 they	
reached	a	count	of	approximately	108	cells/mL	or	105	cells/mL	
for	fungi	[40].	100	μL	of	microbial	suspension	was	spread	onto	
agar	 plates	 corresponding	 to	 the	 broth	 in	 which	 they	 were	
maintained.	 Isolated	 colonies	 of	 each	 organism	 that	might	 be	
playing	a	pathogenic	role	should	be	selected	from	primary	agar	
plates	and	tested	for	susceptibility	by	disc	diffusion	method	of	
the	 National	 Committee	 for	 Clinical	 Laboratory	 Standards	
(NCCLS)	[41].	Of	the	many	media	available,	NCCLS	recommends	
Müeller‐Hinton	 agar	 due	 to	 it	 results	 in	 good	 batch‐to‐batch	
reproducibility.	 The	 petri	 dishes	 were	 incubated	 at	 30	 oC	 for	
fungi	and	at	35‐37	oC	for	bacteria.	The	diameter	of	the	zone	of	
inhibition	was	measured	in	millimeters	after	24	h	of	incubation	
[42].	Standard	discs	of	Gentamicin	and	Ampicillin	(antibacterial	
agents),	 Amphotericin	 B	 (antifungal	 agent)	 served	 as	 positive	
controls	 for	antimicrobial	 activity	but	 filter	discs	 impregnated	
with	10	μL	of	solvent	(DMSO)	were	used	as	a	negative	control.	
The	agar	used	 is	Meüller‐Hinton	agar	 that	 is	 rigorously	 tested	
for	 composition	 and	 pH.	 Further	 the	 depth	 of	 the	 agar	 in	 the	
plate	 is	a	 factor	to	be	considered	in	 the	disc	diffusion	method.	
This	 method	 is	 well	 documented	 and	 standard	 zones	 of	
inhibition	have	been	determined	 for	 susceptible	 and	 resistant	
values.	Blank	paper	disks	(Schleicher	and	Schuell,	Spain)	with	a	
diameter	 of	 8.0	 mm	 were	 impregnated	 with	 10	 μL	 of	 tested	
concentration	 of	 the	 stock	 solutions.	When	 a	 filter	 paper	 disc	
impregnated	 with	 a	 tested	 chemical	 is	 placed	 on	 agar,	 the	
chemical	will	diffuse	from	the	disc	into	the	agar.	This	diffusion	
will	 place	 the	 chemical	 in	 the	 agar	 only	 around	 the	 disc.	 The	
solubility	of	the	chemical	and	its	molecular	size	will	determine	
the	size	of	the	area	of	chemical	infiltration	around	the	disc.	If	an	
organism	 is	 placed	 on	 the	 agar,	 it	 will	 not	 grow	 in	 the	 area	
around	the	disc	if	it	is	susceptible	to	the	chemical.	This	area	of	
no	growth	around	the	disc	is	known	as	a	"Zone	of	inhibition"	or	
"Clear	 Zone".	 For	 the	 disc	 diffusion,	 the	 zone	 diameters	were	
measured	with	slipping	calipers	of	the	NCCLS	[43].	Agar‐based	
methods	 such	 as	 E‐test	 and	 disk	 diffusion	 can	 be	 good	
alternatives	 because	 they	 are	 simpler	 and	 faster	 the	 broth‐
based	methods	[44].		
	
2.5.2.	Minimum	inhibitory	concentration	(MIC)		
	
Compounds	showing	promising	antibacterial	activity	were	
selected	 for	minimum	 inhibitory	 concentration	 (MIC)	 studies.	
The	 MIC	 is	 the	 lowest	 concentration	 of	 the	 test	 compound,	
which	 inhibits	 the	 visible	 growth	 of	 microorganisms	 after	
incubation,	 and	 the	 minimum	 inhibitory	 concentration	 s	 are	
important	 in	diagnostic	 laboratories	 to	 confirm	 the	 resistance	
of	 microorganisms	 to	 antimicrobial	 agents.	 The	 synthesized	
compounds	were	screened	against	bacterial	strains	using	agar	
plate	method,	 two	 fold	 serial	dilutions	of	 each	 test	 compound	
were	used.	The	culture	of	each	organism	was	diluted	by	sterile	
distilled	 water	 to	 105‐106	 CFU/mL.	 The	 cultures	 were	
incubated	with	bacteria	 at	 37	 °C	 for	 24	h.	DMSO	was	used	 as	
negative	control.	
	
2.5.3.	In‐vitro	cytotoxicity	
	
The	 synthesized	 complexes	 were	 screened	 for	 their	
cytotoxicity	 against	 colon	 carcinoma	 (HCT116)	 and	 larynx	
carcinoma	(HEP2)	cells	by	using	the	protocol	of	SRB	assay	[45].	
Cells	were	plated	in	96‐multiwell	plate	(104	cells/well)	for	24	h	
before	 treatment	with	 the	 compounds	 to	 allow	 attachment	 of	
cells	 to	 the	 wall	 of	 plate.	 Different	 concentrations	 of	 the	 test	
chemical	 compound	 were	 added	 to	 the	 cell	 monolayer.	
Triplicate	 wells	 were	 prepared	 for	 each	 individual	 dose	 and	
IC50	 is	 the	 mean	 of	 three	 values.	 Monolayer	 cells	 were	
incubated	for	48	h	at	37	oC	in	air	with	5%	CO2.	After	48	h,	cells	
were	fixed,	washed	and	stained	with	Sulfo‐Rhodamine‐B	stain.	
Excess	 stain	 was	 washed	 with	 acetic	 acid	 and	 attached	 stain	
was	 recovered	 with	 tris‐EDTA	 buffer.	 Color	 intensity	 is	
measured	in	an	ELISA	reader.	The	average	drug	concentration	
(µg/cm3)	 for	 50%	 inhibition	 of	 tumor	 cell‐growth	 was	
determined	 by	 plotting	 the	 surviving	 fraction	 versus	 drug	
concentration	for	each	tumor	cell	line.		
	
2.6.	Instrumentation 
	
Potentiometric	measurements	were	made	using	a	Metrohm	
686	titroprocessor	equipped	with	a	665	Dosimat	(Switzerland‐
Herisau).	A	thermostatted	glass‐cell	was	used	equipped	with	a	
magnetic	 stirring	 system,	 a	 Metrohm	 glass	 electrode,	 a	
thermometric	 probe,	 a	 microburet	 delivery	 tube	 and	 a	 salt	
bridge	 connected	with	 the	 reference	 cell	 filled	with	0.1	M	KCl	
solution	in	which	saturated	calomel	electrode	was	dipped.		
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Table	1.	Analytical	and	physical	data	of	compounds.	
Compound	*	 Yield,	%	 M.wt.,	g
	
%	Found	(Calcd.)
C H N	 S	
ATS	 89	 295.9	 48.49	(48.66)	 3.39	(3.37)	 4.80	(4.73)	 10.89	(10.81)	
[Cu(1,10‐phen)(ATS)(H2O)2]Cl 77		 609.94 47.46	(47.21) 3.49	(3.44) 6.88	(6.88)	 5.39	(5.24)
[Ni(1,10‐phen)(ATS)(H2O)2]Cl	 75	 605.09	 47.46	(47.59)	 3.49	(3.47)	 6.88	(6.94)	 5.39	(5.28)	
[Co(1,10‐phen)(ATS)(H2O)2]Cl	 71	 605.33	 47.46	(47.57)	 3.49	(3.46)	 6.88	(6.93)	 5.39	(5.28)	
[Zn(1,10‐phen)(ATS)]Cl	 73	 575.79	 50.11	(50.02)	 3.02	(2.95)	 7.35	(7.29)	 5.62	(5.55)	
	*	ATS	=	2‐Aminomethylthiophenyl‐4‐bromosalicylaldehyde	and	1,10‐phen	=	1,10‐phenanthroline.	
	
Table	2.	Tentative	assignment	of	the	important	infrared	bands	of	the	synthesized	complexes.		
Complex	* ν	(cm‐1) 
νOH	 νC=N δ(O‐H)	 ν(C‐O)	 Coordinated	H2O	 ν(C‐S‐C)	 νM‐O	 νM‐N
ATS/1,10‐phen	 3361	 1675,	1570	 1361 1319 ‐ 825	 ‐	 ‐
[Cu(1,10‐phen)(ATS)(H2O)2]Cl 3465‐3595	 1657,	1542 1461 1340 779 824	 540 398
[Ni(1,10‐phen)(ATS)(H2O)2]Cl	 3440‐3577 1655,	1543 1463 1338 782 825	 525 391
[Co(1,10‐phen)(ATS)(H2O)2]Cl	 3390‐3560	 1653,	1543 1460 1342 770 823	 512 385
[Zn(1,10‐phen)(ATS)]Cl	 ‐ 1653,	1545	 1459	 1346	 - 826	 505	 375
	*	ATS	=	2‐Aminomethylthiophenyl‐4‐bromosalicylaldehyde	and	1,10‐phen	=	1,10‐phenanthroline.	
	
	
Temperature	 was	 maintained	 constant	 inside	 the	 cell	 at	
25.0±0.02	 oC,	by	 the	circulating	water	by	a	 thermostated	bath	
(Precision±0.02).	 All	 potentiometric	 measurements	 in	 this	
study	 were	 carried	 out	 in	 water‐DMSO	 mixtures	 containing	
70%	DMSO	because	of	 low	solubility	of	Schiff	base	 ligand	and	
possible	 hydrolysis	 in	 aqueous	 solution.	 Elemental	 analyses	
were	 carried	 out	 at	 the	 Department	 of	 Chemistry,	 Faculty	 of	
Science,	 King	 Abdul‐Aziz	 University,	 Jeddah21589,	 KSA.	 The	
analyses	 were	 performed	 twice	 to	 check	 the	 accuracy	 of	 the	
analyses	 data.	 Infrared	 spectra	were	 recorded	 on	 an	8001‐PC	
FTIR	Shimadzu	spectrophotometer	using	KBr	pellets.	The	solid	
reflectance	 spectra	 were	 measured	 on	 a	 Schimadzu	 3101	 pc	
spectrophotometer.	 The	 molar	 conductance	 of	 the	 complexes	
was	measured	for	1.00×10‐3	M	DMSO	solutions	at	25±1	oC	using	
a	 systronic	 conductivity	 bridge	 type	 305.	 The	 room	 tempe‐
rature	magnetic	susceptibility	measurements	for	the	complexes	
were	determined	by	the	Gouy	balance	using	Hg[Co(SCN)4]	as	a	
calibrant.	 The	 1H	NMR	 spectra	were	 recorded	 using	 a	 Bruker	
ARX‐300	instrument.	Chemical	shifts	are	reported	in	parts	per	
million	 (ppm)	 relative	 to	 tetramethylsilane	 using	 deuterated	
DMSO	as	solvent.		
	
2.7.	Potentiometric	titrations 
	
The	 potentiometric	 cell	 was	 calibrated	 before	 each	
experiment	to	convert	the	pH	meter	readings	into	hydrogen	ion	
concentration	as	reported	in	literature	[46].	The	ionic	product	
(Kw	=	[H+][OH‐])	was	calculated	at	a	constant	 ionic	strength	of	
0.10	mol/dm3	with	NaCl	in	70%	aqueous	DMSO	solutions	based	
on	 measurements	 of	 [OH‐]	 and	 pH	 in	 several	 series	 of	
experiments.	We	calaculated	the	reproducible	values	of	pKw	for	
the	 examined	 70%	 aqueous	 dimethyl	 sulfoxide	 solution	 [47].	
The	pKw	value	obtained	is	15.75(±	0.2)	in	this	medium.	 
Potentiometric	 titrations	 were	 carried	 out	 at	 constant	
temperature	and	in	an	inert	atmosphere	of	nitrogen	with	CO2‐
free	 standardized	0.05	mol/dm3	NaOH	as	 titrant	 in	a	40.0	mL	
solution	 at	 constant	 ionic	 strength	 of	 0.1	 mol/dm3	 NaCl.	 The	
proton	association	constants	of	the	ATS	ligand	was	determined	
potentiometrically	 by	 titrating	 (1.25×10‐3	 M)	 of	 the	 ligand	
solution	 (40	 cm3).	 The	 stability	 constants	 of	 the	 binary	
complexes	 were	 determined	 using	 potentiometric	 data	
obtained	 from	 (40	 cm3)	 mixture	 containing	 CuCl2.2H2O/	
CoCl2.6H2O/NiCl2.6H2O/ZnCl2.2H2O	 (1.25×10‐3	 M)	 +	 (ATS)	
(2.5×10‐3	M	).		
The	 potentiometric	 cell	 was	 calibrated	 before	 each	
experiment	 so	 as	 to	measure	 the	 hydrogen	 ion	 concentration	
rather	than	its	activity.	The	pH‐meter	readings	(B)	recorded	in	
DMSO‐water	 solutions	 were	 converted	 to	 hydrogen	 ion	
concentration	 [H+]	by	using	 the	widely	used	 relation	given	by	
Van	Uitert	and	Hass	Equation	(1)	[48]	as	shown	below.	
	
−Log	[H+]	=	B	+	Log	UH		 	 	 	 (1)	
	
where	 log	 UH	 is	 the	 correction	 factor	 for	 the	 solvent	
composition	and	ionic	strength	for	which	B	is	read.	 
The	equilibrium	constants	evaluated	from	the	titration	data	
are	defined	by	Equations	(2)	and	(3),	where	M,	L	and	H	stand	
for	the	metal(II)	ion	(Cu2+,	Zn2+,Co2+and	Ni2+),	Schiff	base	ligand	
(ATS)	and	proton,	respectively.		
		
pM	+	qL	+	rH	⇌	MpLqHr		 	 	 	 (2)	
	
βpqr=
[MpLqHr]
[M]p[L]q[H]r													 	 	 	 (3)	
	
The	calculations	were	obtained	from	ca.	100	data	points	in	
each	titration	using	the	computer	program	MINIQUAD‐75	[49].	
The	 stoichiometry	 and	 stability	 constants	 of	 the	 complexes	
formed	 were	 determined	 by	 trying	 various	 possible	
composition	 models.	 The	 model	 selected	 gave	 the	 best	
statistical	 fit	 and	was	 chemically	 consistent	with	 the	 titration	
data	without	giving	any	systematic	drifts	 in	 the	magnitudes	of	
various	 residuals,	 as	 described	 elsewhere	 [49].	 The	 fitted	
model	was	tested	by	comparing	the	experimental	titration	data	
points	 and	 the	 theoretical	 curve	 calculated	 from	 the	values	of	
the	acid	dissociation	 constant	of	 the	 ligand	and	 the	 formation	
constants	of	the	corresponding	complexes.		
	
3.	Results	and	discussion	
	
3.1.	Elemental	analysis	
	
The	elemental	analysis	data	of	the	mixed‐ligand	complexes	
are	given	in	Table	1.	The	analytical	data	of	the	complexes	show	
the	 formation	 of	 1:1:1	 [M:	 1,10‐phen:	 ATS]	 ratio,	 where	 M	
represents	Cu(II),	Ni(II),	Zn(II)	and	Co(II)	ions,	ATS,	represents	
the	 deprotonated	 Schiff	 base	 while	 1,10‐phen	 represents	 the	
neutral	 bidentate	 1,10‐phenanthroline.	 The	 analytical	 data	 of	
the	 metal	 complexes	 with	 the	 stoichiometries	 proposed	 are	
summarized	in	Table	1.	The	isolated	solid	complexes	are	stable	
in	air.	The	molar	conductance	 indicates	 that	all	 the	complexes	
are	 electrolytic	 in	 nature.	 Elemental	 analyses	 data	 were	 in	 a	
good	agreement	with	those	required	for	the	suggested	formula.	
	
3.2.	IR	spectra	and	mode	of	bonding	
	
The	 IR	spectral	data	 for	 the	complexes	are	summarized	 in	
Table	2,	together	with	assignments	for	most	of	the	major	peaks.	
In	order	to	study	the	binding	mode	of	the	Schiff	base	ligand	to	
the	metal	 ions	in	complexes,	the	IR	spectrum	of	the	free	Schiff	
base	ligand	was	compared	with	the	spectra	of	the	complexes.		
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Table	3.	Molar	conductance,	magnetic	moment	and	electronic	spectral	data	of	mixed‐ligand	complexes.	
Complex	a	 ΛM	b	 μeff	(B.M.)	 λmax	(cm‐1)	
d‐d transition Assignment	 Geometry
[Cu(1,10‐phen)(ATS)(H2O)2]Cl 72	 1.97	 15384		
20325	
24390		
2B1g	→	2B2g	
2B1g	→	2A1g	
2B1g	→	2Eg	
Octahedral	
[Ni(1,10‐phen)(ATS)(H2O)2]Cl	 76	 2.93 10989
16393	
21740	
3A2g	→	3T2g(F)	
3A2g	→	3T1g(F)	
3A2g	→	3T1g(P)	
Octahedral
[Co(1,10‐phen)(ATS)(H2O)2]Cl	 74	 4.98 11210
19607	
4T1g	→	4T2g(F)	
4T1g	→	4A2g(F)	
Octahedral 
[Zn(1,10‐phen)(ATS)]Cl	 73	 Diamag.	 - - Tetrahedral	
a	ATS	=	2‐Aminomethylthiophenyl‐4‐bromosalicylaldehyde	and	1,10‐phen	=	1,10‐phenanthroline.	
b	Molar	conductance	measured	for	10‐3	M	DMSO	solution,	Ω‐1.cm2.mol‐1.		
	
	
The	IR	spectrum	of	ligand	(ATS)	reveals	a	broad	band	in	the	
3361‐3543	 cm‐1	 region	 assigned	 to	 the	 to	 ν(OH)	 group.	 The	
disappearance	 of	 this	 band	 in	 the	 spectra	 of	 the	 complexes	
indicates	 the	 deprotonation	 of	 the	 hydroxyl	 group	 and	
coordination	through	deprotonated	phenolic	OH	group	[50,51].	
The	band	observed	for	ATS	ligand	at	1319	cm‐1	[52]	due	to	ν(C‐
O)	 stretching	 frequency	 (aromatic	 carbon	 and	 phenolic	
oxygen),	 shifted	 to	 lower	 frequency	 by	 19‐27	 cm−1	 in	 the	
mixed‐ligand	complexes	suggesting	involvement	of	the	oxygen	
atom	 to	 the	 metal	 ion	 and	 formation	 of	 M‐O	 bond	 via	
deprotonation.	However,	the	strong	band	observed	at	1675	cm‐
1	 in	 the	 free	 ATS	 Schiff	 base	 ligand	 is	 assigned	 to	 the	
azomehtine	group	vibration.	This	band	is	shifted	towards	lower	
frequencies	 by	 18‐22	 cm‐1	 in	 the	 complexes,	 indicating	
coordination	 of	 the	 imine	 nitrogen	 atom	 to	 the	 metal	 ion	
[53,54].	In	the	free	Schiff	base	ligand,	the	sharp	band	observed	
at	 825	 cm‐1	 is	 due	 to	 ν(C–S‐C)	 stretching	 frequency	 of	
thiophene	 ring.	 In	 all	 complexes,	 this	 band	 remains	 quite	
unchanged	 confirming	 the	 noninvolvement	 of	 the	 thiophene	
sulfur	 in	complex	 formation	 [55].	The	 IR	spectrum	of	 the	 free	
1,10‐phen	 ligand	 shows	 a	 very	 stronger	 bands	 at	~1570	 cm‐1	
due	 to	 stretching	 frequency	 of	 C=N	 present	 in	 1,10‐
phenanthroline	 moiety.	 This	 band	 was	 shifted	 to	 lower	
frequencies	 in	 the	 complexes	 ~25‐28	 cm‐1,	 which	 clearly	
indicate	that	the	coordination	of	the	two	nitrogen	atoms	of	the	
neutral	1,10‐phen	ligand	to	M(III)	ion	upon	complexation.	The	
presence	 of	 coordinated	 water	 molecules	 are	 observed	 by	
broad	 bands	 around	 3390‐3595	 cm‐1;	 assigned	 to	 the	
symmetric	 and	 antisymmetric	 –OH	 stretching	 modes.	 This	 is	
further	confirmed	by	bands	observed	at	770‐782	cm‐1	[56]	and	
each	 of	 these	 bands	 is	 assigned	 to	 the	 coordinated	 water	
molecules.	 Two	 new	 bands	 appearing	 in	 the	 low	 frequency	
ranges	505‐540	and	375‐398	cm‐1	 are	 assigned	 to	 the	υ(M‐O)	
and	 υ(M‐N)	 vibrations	 [57]	 respectively,	 supporting	 the	
participation	of	the	nitrogen	atom	of	the	azomethine	group	and	
oxygen	of	the	OH	group	of	the	ligand	in	the	complexation	with	
metal	 ions	 [56].	 The	values	 of	υ(M–O)	 and	υ(M–N)	 follow	 the	
order	 Cu	 >	 Ni	 >	 Co	 >	 Zn,	 in	 parallel	 with	 the	 crystal	 field	
stabilization	energies	[58,59].	
	
3.3.	Molar	conductance	measurements	
	
The	molar	conductivities	of	1×10–3	M	of	the	isolated	metal	
chelate	solutions	at	25±1	°C	were	measured	and	the	measured	
values	 were	 recorded	 in	 Table	 3.	 It	 is	 clear	 from	 the	
conductivity	 data	 (72‐76	 Ω‐1.cm2.mol‐1)	 that	 the	 complexes	
present	seem	to	be	electrolytes.	
	
3.4.	Magnetic	moment	and	electronic	spectra		
	
The	 electronic	 spectral	 data	 along	 with	 magnetic	
susceptibility	 measurements	 gave	 adequate	 support	 in	
establishing	 the	 geometry	 of	 the	 metal	 complexes.	 The	 solid	
reflectance	spectra	of	metal	complexes	show	different	bands	at	
different	 wavelengths,	 each	 one	 is	 corresponding	 to	 certain	
transition	 which	 suggests	 the	 geometry	 of	 the	 complex	
compounds.	 The	 magnetic	 moments	 of	 the	 complexes	 were	
measured	 at	 room	 temperature.	 These	 data	 along	 with	 the	
tentative	 assignments	 of	 spectral	 bands	 and	 the	 magnetic	
moment	values	are	presented	in	Table	3.		
	
3.4.1.	Magnetic	moment		
	
The	 magnetic	 susceptibility	 measurements	 in	 the	 solid	
state	 show	 that	 the	 present	 complexes	 are	 paramagnetic	 at	
room	 temperature.	 For	 the	 [Cu(1,10‐phen)(ATS)(H2O)2]	
complex;	the	magnetic	moment	is	equal	to	1.97	B.M.	(Table	3)	
which	assigned	 to	octahedral	geometry.	Ni(II)	 complex	gave	a	
magnetic	 moment	 of	 2.93	 B.M.	 and	 hence	 assigned	 as	
octahedral,	 because	 of	 the	 square	 planar	 complexes	 of	 Ni(II)	
are	a	diamagnetic	while	 tetrahedral	complexes	have	moments	
in	 the	 range	 3.20‐4.10	 B.M.	 [60].	 The	 Co(II)	 octahedral	
complexes	 generally	 show	 magnetic	 moments	 (eff)	 between	
4.7‐5.2	B.M.	because	of	the	orbital	contribution	[60].	Since	the	
orbital	 contribution	 of	 tetrahedral	 Co(II)	 complexes	 have	
generally	 lower	magnetic	moments	 (3.87	B.M.),	 as	 compared	
to	 that	 of	 octahedral	 complexes	 (4.7‐5.2	 BM)	 [61].	 Co(II)	
complex	 showed	 a	 magnetic	 moment	 of	 4.98	 B.M.	 at	 room	
temperature	 suggesting	 consistency	 with	 its	 octahedral	
environment.	
	
3.4.2.	Electronic	spectra	
	
Three	 spin	 allowed	 transitions	 may	 be	 expected	 for	 six	
coordinated	 copper	 (II)	 complex	 in	 the	 visible	 region	 and	 the	
2Eg	and	2T2g	levels	of	2D	free	ion	will	split	into	2B1g,	2A1g,	2B2g	and	
2Eg	 levels,	 respectively.	Copper	 (II)	 complex	 spectrum	showed	
three	 bands	 at	 15384	 (ν1),	 20325(ν2)	 and	 24390	 cm−1	 (ν3),	
corresponding	to	the	following	transitions	2B1g	→	2A1g	(dx2‐y2	→	
dz2)	ν1,	 2B1g	→	2B2g	(dx2‐y2	→	dzy)	ν2	and	2B1g	→	2Eg	(dx2‐y2	→	dzy,	
dyz)	 ν3	 (Table	 3)	 and	 this	 is	 consistent	 with	 an	 octahedral	
configuration	 [7].	 The	 solid	 reflectance	 spectrum	 of	 the	
[Ni(1,10‐phen)(ATS)(H2O)2]Cl	 complex	 shows	 three	 bands	 in	
the	near	IR–visible	region	at	ν1	=	10989	cm‐1	[3A2g	→	3T2g],	ν2	=	
16393	 cm‐1	 [3A2g	 →	 3T1g(F)]	 and	 ν3	 =	 21740	 cm‐1	 [3A2g	 →	
3T1g(P)].	These	frequencies	are	well	within	the	range	expected	
for	 octahedral	 Ni(II)	 complexes	 [7,61].	 The	 Co(II)	 complexes	
generally	 give	 rise	 to	 three	 absorption	 bands	 in	 the	 visible	
region	 under	 the	 influence	 of	 the	 octahedral	 field	 by	 the	
excitation	of	the	electron	from	the	ground	state	4T1g	(F)	to	the	
excited	 states	 4T2g	 (F),	 4A2g	 (F)	 and	 4T1g	 (P).	 In	 the	 [Co(1,10‐
phen)(ATS)(H2O)2]Cl	complex,	only	two	bands	are	observed	at	
11210	cm–1	4T1g	(F)	→	4T2g	(F)	(1)	and	19607	cm–1	4T1g	(F)	→	
4T1g	 (P)	 (3)	 as	 reported	 in	 many	 octahedral	 cobalt(II)	
complexes.	 The	 ν2	 transition	 was	 not	 observed	 due	 to	 very	
weak	 intensity	 [7,62].	 No	 d‐d	 transitions	 are	 expected	 for	 d10	
Zn(II)	 complexes.	 In	 analogy	 with	 those	 described	 for	 Zn(II)	
complexes	containing	N–O	donors	[63,64]	and	according	to	the	
empirical	 formula	 of	 Zn(II)	 complex,	 it	 is	 likely	 to	 be	
tetrahedral	 in	 accordance	 with	 the	 preference	 of	 Zn(II)	 for	
tetrahedral	coordination	[65].		
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Table	5.	Some	selected	geometric	parameters	(Å)	for	the	studied	M(II)	complexes.	
Complex	a	 M‐N12	 M‐N24	 M‐N3	 M‐O	 	M‐OH2	 M‐OH2	
[Cu(1,10‐phen)(ATS)(H2O)2]Cl 1.988 1.986 1.941 1.901 1.915	 1.920
[Ni(1,10‐phen)(ATS)(H2O)2]Cl	 1.875 1.868 1.853 1.808 1.798	 1.807
[Co(1,10‐phen)(ATS)(H2O)2]Cl	 1.870 1.823 1.791 1.759 1.843	 1.842
[Zn(1,10‐phen)(ATS)]Cl	b	 1.825 1.791 1.823 1.759 ‐	 ‐
a	ATS	=	2‐Aminomethylthiophenyl‐4‐bromosalicylaldehyde	and	1,10‐phen	=	1,10‐phenanthroline.	
b	Tetrahedral	for	Zn(II)‐complex.	
	
Table	6.	Natural	charge	and	the	electron	configuration	adopted	by	the	central	metal	ion	in	the	synthesized	complexes.		
Complex	a	 Charge		 Core	 Valence Rydberg Total Configuration
[Cu(1,10‐phen)(ATS)(H2O)2]Cl 0.78805	 17.995	 10.207	 0.0108	 28.212	 [core]	4s(0.28),	3d(9.38),	4p(0.19),	5p(	0.36)	
[Ni(1,10‐phen)(ATS)(H2O)2]Cl	 0.67153		 17.991	 9.3199 0.0172 27.328 [core]	4s(0.28),	3d(8.47),	4p(0.57),	4d(0.01),	5p(0.01)
[Co(1,10‐phen)(ATS)(H2O)2]Cl	 0.42880		 17.989	 8.557	 0.025	 26.571	 [core]	3d(7.75),	4p(0.37),	5s(0.27),	4d(0.02),	5p(0.17)	
[Zn(1,10‐phen)(ATS)]Cl	b	 1.24879		 18.000	 10.742	 0.0096	 28.751	 [core]	4s(0.31),	3d(9.94),	4p(0.50)	
a	ATS	=	2‐Aminomethylthiophenyl‐4‐bromosalicylaldehyde	and	1,10‐phen	=	1,10‐phenanthroline.	
b	Tetrahedral	for	Zn(II)‐complex.	
	
Table	7.	Stability	constants	(Log	β)	of	binary	species	in	the	M(II)‐ATS	25	oC	and	0.1	mol/dm3	ionic	strength	using	NaCl.	
Compound	a	 p	 q	 r	b Log	β	±	σ	c S	d	
ATS	 0	 1	 1	 10.12±0.02	 1.9×10‐8	
0	 1	 2	 17.73±0.01		
Cu(II)‐ATS	 1	 1	 0	 9.64±0.03	 2.5×10‐7	
1	 2	 0 16.68±0.02
Ni(II)‐ATS	 1	 1	 0	 7.11±0.04	 2.9×10‐7	
1	 2	 0 12.29±0.06
Co(II)‐ATS	 1	 1	 0 6.60±0.02 5.3×10‐7	
1	 2	 0	 11.13±0.05	
Zn(II)‐ATS	 1	 1	 0	 6.29±0.03	 9.1×10‐7	
1	 2	 0	 10.62±0.07	
a	ATS	=	2‐Aminomethylthiophenyl‐4‐bromosalicylaldehyde.	
b	p,	q	and	r	are	stoichiometric	coefficients	corresponding	to	M(II),	ATS,	and	H+,	respectively.	
c	Standard	deviation.		
d	Sum	of	square	of	residuals.	
	
Table	8.	Antibacterial	activity	of	bivalent	transition	metal	ion	mixed‐ligandransition	metal	complexes.	
Complexes	a	 Diameter	of	inhibition	zone	(in	mm)	b/	(MIC)	c
G‐	 G+	
Shigella	flexneri Proteous	vulgaris Bacillus	subtillis Staphylococcus	aureus
[Cu(1,10‐phen)(ATS)(H2O)2]Cl 17.7±0.67	(31.25)	 18.4±0.53	(7.81)	 20.4±0.38	(7.81)	 22.3±0.56	(3.91)	
[Ni(1,10‐phen)(ATS)(H2O)2]Cl	 16.4±0.43	(62.5)	 15.3±0.32	(62.5)	 12.4±0.58	(62.25)	 14.2±0.29	(25.97)	
[Co(1,10‐phen)(ATS)(H2O)2]Cl	 ‐	 13.4±0.63	(125) 15.5±0.25	(12.5) 13.9±0.29	(62.5)	
[Zn(1,10‐phen)(ATS)]Cl	 22.7±0.31	(0.48) 23.6±0.39	(9.9) 24.7±0.28	(0.06) 25.8±0.19	(0.24)	
Gentamicin	and	Ampicillin	(Standard)	d	 24.8±0.24	(0.48) 23.4±0.3	(1.95) 34.6±0.35	(0.007) 28.9±0.14	(0.06)	
a	ATS	=	2‐Aminomethylthiophenyl‐4‐bromosalicylaldehyde	and	1,10‐phen	=	1,10‐phenanthroline.	
b	Mean	zone	of	inhibition	in	mm	±	standard	deviation.	
c	Minimium	inhibitory	concentration	(μg/mL)	of	tested	samples	against	tested	microorganisms,	“‐“	:	no	activity.	
d	Standard	discs	of	Gentamicin	for	G‐	and	Ampicillin	for	G+	are	used	as	antibacterial	agents.		
	
	
A	 further	 advantage	 is	 its	 compatibility	with	 the	 standard	
glass	 electrode,	 so	 that	 the	 pH	measurements	may	 be	 carried	
out	 in	 a	 similar	 way	 to	 that	 employed	 in	 a	 purely	 aqueous	
solution.	In	contrast,	the	use	of	pure	DMSO	is	not	recommended	
for	potentiometry.	Another	advantage	of	the	DMSO:water	(7:3)	
mixture	 is	 its	 large	 acidity	 range	 (pKw	 =	 15.75)	which	 allows	
the	 investigation	 of	 deprotonation	 equilibria	 of	 weak	 acids	
which	 could	 be	 hardly	 studied	 in	 water	 [72,73].	 The	
equilibrium	 studies	 were	 determined	 in	 70%	 DMSO‐water	
mixture	at	25	oC	and	these	constants	are	 tabulated	in	Table	7.	
Analysis	 of	 the	 potentiometric	 titration	 curve	 using	 the	
program	 Miniquad‐75	 gave	 best	 fit	 for	 two	 protonation	
constants	 (Table	 7)	 for	 the	 Schiff‐base	 ligand.	 Potentiometric	
titrations	of	ATS	with	Zn(II),	Cu(II),	Ni(II)	and	Co(II)	ions	were	
carried	out	in	1:1	and	1:2	metal‐ligand	molar	ratios	at	I	=	0.1	M	
NaCl	and	25	oC	 in	DMSO:water	(7:3)	mixture.	The	deviation	in	
the	metal‐ligand	titration	curves	from	the	ligand	titration	curve	
implies	 the	 formation	 of	 metal	 complexes.	 The	 overall	
formation	 constants	 (Log	 β)	 of	 the	 species	 were	 calculated	
using	Miniquad‐75	program	(Table	7).		
The	complex	forming	ability	of	the	transition	metal	ions	are	
frequently	characterizes	by	stability	orders.	It	can	be	seen	that	
log	K	arranged	in	the	order	Zn(II)	<	Cu(II)	>	Ni(II)	>	Co(II)	is	in	
accordance	with	 Irving–William’s	 order	 for	 divalent	metals	 of	
3d	series	[74].	In	general,	it	is	noted	that	the	stability	constant	
of	 the	 Cu(II)	 complex	 is	 quite	 large	 compared	 to	 the	 other	
metals.	The	ligand	field	will	give	Cu(II)	some	extra	stabilization	
due	to	tetragonal	distortion	of	the	octahedral	symmetry	[75].		
	
3.9.	Biological	activity	
	
3.9.1.	Antibacterial	and	antifungal	activities	
	
The	 metal	 complexes	 were	 tested	 for	 their	 inhibitory	
effects	on	the	growth	of	Staphylococcus	aureus,	Bacillus	subtillis,	
Shigella	flexneri,	Proteous	vulgaris	bacteria	because	bacteria	can	
achieve	 resistance	 to	 antibiotics	 through	 biochemical	 and	
morphological	 modifications	 [76].	 The	 antibacterial	 and	
antifungal	 activities	 of	 the	 new	 compounds	 are	 presented	 in	
Tables	8	 and	9	 respectively.	 It	 is	 observed	 that	 the	activity	of	
ternary	 complexes	 is	 more	 compared	 to	 their	 corresponding	
binary	 complexes	 [20].	 This	 result	 is	 expected	 since	 the	
complexes	possess	a	greater	planar	area	and	π‐systems	which	
make	 stacking	 more	 strongly.	 The	 biological	 activity	 of	
complexes	may	be	arise	 from	 the	hydroxyl	groups	which	may	
play	an	important	role	in	the	antibacterial	activity	[77],	as	well	
as	the	presence	of	imine	group	which	imports	in	elucidating	the	
mechanism	 of	 transformation	 reaction	 in	 biological	 systems	
[78].	 The	 antimicrobial	 activity	 can	 be	 ordered	 as	 [Zn(1,10‐
phen)(ATS)]	 >	 [Cu(1,10‐phen)(ATS)(H2O)2]	 >	 [Ni(1,10‐
phen)(ATS)(H2O)2]	 >	 [Co(1,10‐phen)(ATS)(H2O)2]	 (Figure	 4),	
suggesting	 that	 the	 lipophilic	 behavior	 increases	 in	 the	 same	
order.		
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Table	9.	Antifungal	activity	of	mixed‐ligand	complexes.		
Complex	a	 Diameter	of	inhibition	zone	(in	mm)	b/	(MIC)	c	
Aspergillus	fumigatus Candida	albicans	
[Cu(1,10‐phen)(ATS)(H2O)2]Cl 20.3±0.35	(7.81) 17.8±0.23	(3.90)	
[Ni(1,10‐phen)(ATS)(H2O)2]Cl	 16.7±0.23	(15.63)	 13.8±0.53	(15.63)	
[Co(1,10‐phen)(ATS)(H2O)2]Cl	 15.7±0.23	(62.5) 12.2±0.36	(31.26)	
[Zn(1,10‐phen)(ATS)]Cl	 21.4±0.53	(7.81) 20.3±0.24	(1.95)	
Amphotericin	B	(Standard)	d	 23.7±0.10	(0.97) 26.4±0.20	(0.48) 
a	ATS	=	2‐Aminomethylthiophenyl‐4‐bromosalicylaldehyde	and	1,10‐phen	=	1,10‐phenanthroline.	
b	Mean	zone	of	inhibition	in	mm	±	standard	deviation.	
c	Minimium	inhibitory	concentration	(μg/mL)	of	tested	samples	against	tested	microorganisms.	
d	Standard	discs	of	Amphotericin	B	is	used	as	antifungal	agent.	
	
	
	
Figure	4.	Antibacterial	activity	of	mixed‐ligand	complexes.
	
Since	all	complexes	(i)	have	the	same	donating	atoms	which	
are	N/O,	(ii)	have	the	same	chelate	effect	(all	form	two	five	and	
six‐membered	chelating	rings),	(iii)	have	the	same	charge	and	
the	same	counter	ion,	and	(iv)	have	the	same	oxidation	number	
in	their	complexes	(M(II)),	therefore,	the	more	effective	factors	
are	the	geometrical	shape	and	the	nature	of	the	central	atoms.	
According	 to	 the	 spectral	 and	magnetic	 studies,	 (i)	 zinc	 has	 a	
tetrahedral	 geometry;	 (ii)	 copper;	 cobalt	 and	 nickel	 have	
octahedral	 structure.	 Therefore,	 the	 higher	 antimicrobial	
activity	of	Zn(II)	complex	can	be	referred	to	its	structure	which	
is	 the	 tetrahedral.	 Comparison	of	 the	biological	 activity	 of	 the	
synthesized	 compounds	with	Amphotericin	 B	 shows	 generally	
the	 complexes	 exhibit	 better	 activity	 or	 have	 a	 comparable	
effect.	The	synthesized	Zn(II)	complex	is	active	against	Candida	
albicans	with	MIC	value	of	1.95	μg/mL	versus	candida	albicans.	
The	 antifungal	 activity	 was	 given	 in	 Figure	 5.	 The	 tested	
complexes	were	more	active	against	Gram‐positive	than	Gram‐
negative	 bacteria,	 it	 may	 be	 concluded	 that	 the	 antimicrobial	
activity	of	the	compounds	is	related	to	cell	wall	structure	of	the	
bacteria.	 Gram‐positive	 bacteria	 possess	 a	 thick	 cell	 wall	
containing	many	layers	of	peptidoglycan	and	teichoic	acids,	but	
in	 contrast,	 Gram	negative	 bacteria	 have	 a	 relatively	 thin	 cell	
wall	 consisting	 of	 a	 few	 layers	 of	 peptidoglycan.	 These	
differences	 in	 cell	 wall	 structure	 can	 produce	 differences	 in	
antibacterial	 susceptibility	 and	 some	 antibiotics	 can	 kill	 only	
Gram‐positive	 bacteria	 and	 is	 infective	 against	 Gram‐negative	
pathogens	[7,20,28,79‐81].	
	
		
Figure	5.	Antifungal	activity	of	mixed‐ligand	complexes.	
	
3.9.2.	Cytotoxic	activities	
	
In	 vitro	 potential	 cytotoxicity	 of	 Cu(II),	 Ni(II)	 and	 Zn(II)	
complexes	was	 tested	 against	 colon	 carcinoma	 (HCT116)	 and	
larynx	carcinoma	(HEP2)	cells.	The	relation	between	surviving	
fraction	 and	 drug	 concentration	 is	 plotted	 to	 get	 the	 survival	
curve	of	each	tumor	cell	 line,	Figure	6,	 IC50	values	are	cited	in	
Table	 10.	 Cytotoxic	 study	 of	 the	 compounds	 against	 colon	
carcinoma	 (HCT116)	 and	 larynx	 carcinoma	 (HEP2)	 cells	
indicate	 that,	 [Cu(1,10‐phen)(ATS)(H2O)2]	 and	 [Zn(1,10‐
phen)(ATS)]complexes	show	significant	activity	against	 larynx	
cancer	 cells	 with	 IC50	 values	 of	 0.56	 and	 0.45	 g/mL,	
respectively	 (Figure	 6)	 classifying	 these	 compounds	 as	
chemotherapeutically	 significant.	 IC50	 is	 the	 concentration	
which	can	reduce	the	growth	of	cancer	cells	by	50%.	The	rank	
order	of	potency	as	a	function	of	chelated	metal	ion	follows	the	
order	Co	<	Ni	<	Cu	<	Zn	against	HEP2	cancer	cells.	Results	show	
that	the	growth	inhibition	of	tumor	cells	is	due	to	apoptosis	in	
metal	 complexes.	 In	 conclusion,	 the	 Zn‐complex	 exhibits	
significant	decrease	in	surviving	fraction	of	HCT116	and	HEP2	
cancer	cells	and	induced	apoptosis	of	these	cell	lines.	
	
		
		
Figure	 6.	 Effect	 of	 [Cu(1,10‐phen)(ATS)(H2O)2]	 and	 [Zn(1,10‐phen)(ATS)]	
complexes	on	surviving	fraction	of	HEP2	tumor	cells.	
	
3.10.	Structure	of	the	complexes	
	
Single	crystals	of	the	complexes	could	not	be	isolated	from	
any	 solutions;	 thus,	 no	 definitive	 structure	 can	 be	 described.	
However,	 it	 is	 concluded	 that	 from	elemental	 analysis,	 IR	 and	
1H	 NMR	 spectra,	 the	 Schiff	 base	 ligand	 (ATS)	 behaves	 as	 a	
bidentate	 ligand	 coordinated	 to	 the	 metal	 ions	 Cu(II),	 Ni(II),	
Co(II)	and	Zn(II)	through	the	phenolate	oxygen	and	azomethine	
group	 while	 1,10‐phen	 acts	 as	 a	 neutral	 bidentate	 ligand	
coordinated	through	the	pyridine	nitrogen	atoms	(Figure	7).		
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Table	10.	Effect	of	synthesized	metal	complexes	on	tumor	cell	growth	in	vitro	(IC50	values	in	μg/mL).	
Compounds	a	 IC50	b	
HCT116 HEP2	
[Cu(1,10‐phen)(ATS)(H2O)2]Cl 1.73	 0.53	
[Ni(1,10‐phen)(ATS)(H2O)2]Cl	 1.92	 0.62	
[Co(1,10‐phen)(ATS)(H2O)2]Cl	 2.21 0.77	
[Zn(1,10‐phen)(ATS)]Cl	 1.28 0.44	
Doxorubicin	(Standard)	 0.69 0.40	
a	ATS	=	2‐Aminomethylthiophenyl‐4‐bromosalicylaldehyde	and	1,10‐phen	=	1,10‐phenanthroline.	
b	IC50	=cytotoxic	dose	at	50%,	i.e.	the	drug	concentration	to	inhibit	the	growth	of	the	cancer	cells	by	50%.	
	
	
 M	=	Zn(II)	M	=	Cu(II);	Co(II);	Ni(II)	
	
Figure	7.	Suggested	structure	of	the	mixed‐ligand	M(II) complexes.
	
	
On	 the	 basis	 of	 the	 elemental	 analysis	 and	 spectral	 data	
octahedral	 geometry	 is	 suggested	 for	 all	 investigated	
complexes	except	Zn(II)	complex	is	a	tetrahedral	
	
4.	Conclusions	
	
The	 present	 paper	 reports	 on	 the	 synthesis,	
characterization	and	biological	 activity	of	 [M(1,10‐phen)(ATS)	
(H2O)2]	 complexes.	 The	 synthetic	 procedure	 in	 this	 work	
resulted	 in	 the	 formation	 of	 complexes	 in	 the	 molar	 ratio	
(1:1:1)	 (M	 :	 1,10‐phen	 :	 ATS)	 respectively.	 From	 the	 molar	
conductance	 data,	 it	was	 found	 that	 all	 the	M(II)	 chelates	 are	
considered	 as	 1:1	 electrolytes.	 On	 the	 basis	 of	 the	 analytical,	
conductivity,	magnetic	data,	 infrared,	molecular	modeling	and	
electronic	 spectral	 data,	 octahedral	 geometry	were	 concluded	
for	 all	 investigated	 complexes	 except	 Zn(II)	 complex	 is	 a	
tetrahedral.	Based	on	these	observations,	metal	ion	coordinates	
through	phenolate	oxygen,	azomethine	nitrogen	of	Schiff	base,	
and	nitrogen	atoms	of	phenanthroline.	 In	the	absence	of	X‐ray	
single	 crystal	 data	 of	 the	 current	 synthesized	 complexes	 and	
based	 on	 the	 physicochemical	 studies	 and	 geometrical	
optimization,	a	tentative	structure	could	be	proposed	as	shown	
in	Figs.	1	 and	2.	The	antimicrobial	 study	 reveals	 that	 some	of	
the	synthesized	complexes	show	better	activity	or	comparable	
activity	 to	 the	 standard	 drug	 antibiotic.	 The	metal	 complexes	
were	 more	 active	 against	 Gram‐positive	 (Staphylococcus	
aureus,	Bacillus	 subtillis)	 than	Gram‐negative	(Shigella	 flexneri,	
Proteous	vulgaris)	bacteria.	The	antibacterial	 activity	of	mixed	
ligand	complexes	 is	 larger	 than	 that	of	ATS	binary	complexes.	
Also,	 the	 results	 indicated	 that	 tested	 complexes	 were	 more	
active	 against	 Gram‐positive	 than	 Gram‐negative	 bacteria.	 It	
may	be	concluded	that	antibacterial	activity	of	the	compounds	
is	 related	 to	 cell	 wall	 structure	 of	 the	 bacteria.	 It	 is	 possible	
because	 the	 cell	 wall	 is	 essential	 to	 the	 survival	 of	 many	
bacteria	 and	 some	 antibiotics	 are	 able	 to	 kill	 bacteria	 by	
inhibiting	 a	 step	 in	 the	 synthesis	 of	 peptidoglycan.	 The	
antitumor	 activity	 of	 complexes	 displayed	 good	 cytotoxic	
activities	 against	 the	 investigated	 cancer	 cell	 lines.	 The	
importance	of	such	kind	of	work	lies	in	the	possibility	that	the	
new	compounds	might	be	more	effective	against	microbes	 for	
which	 a	 thorough	 study	 regarding	 the	 structure‐activity	
relationship.	
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